Prescribing in the Elderly. Dr Alison Macrae and Dr Debbie Vest GPST2 Drs in Psychiatry

Similar documents
PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

Pharmaceutical Care of People with Atrial Fibrillation. Course activities

Medication Reviews within Care Homes. Catherine Armstrong

Pharmacology in the Elderly

Managing medicines in older people. Jane Noble and Caroline Ralph

Intelligent Polypharmacy. Professor Colin P Bradley Department of General Practice University College Cork

Reviewing Medicines in at risk patients care homes

Pharmaceutical Care for Geriatrics

CARDIAC REHABILITATION PROGRAMME:- MEDICATION

Let it go! Rationalising medicines for patients with life limiting illness

Deprescribing with Confidence Dr Sanjay Suman MD FRCP

Intervention Study 2016 West ISD. Gillian Ritchie Clinical Pharmacist

Deprescribing Unnecessary Medications: A Four-Part Process

Screening tools for elderly patients in primary care

STOPP START Toolkit Supporting Medication Review in the Older Person

Patient Profile. Patient s details Initials: IF Age: 40 Gender: Male. Weight: 139.7kg Height: 510 metres BMI: >47

NES Asthma Hospital Medication Care Plan 7

ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS

Pitfalls in Pharmacotherapy of Geriatrics

Polypharmacy: Guidance for Prescribing in Frail Adults

Care homes: Good practice guide to prescribing and medication reviews

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

Pharmaceutical Care of people with heart failure. Course activities

Medication and Dysphagia To crush or not to crush? Paresh Parmar Care of Elderly & Stroke Pharmacist Northwick Park Hospital

BJF Acute Pain Team Formulary Group

DEPRESCRIBING IN THE ELDERLY

GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA

Taking the harm out of Polypharmacy Step by step. Karen Reid and Claire Stein Lead Integrated Care Pharmacist NHS Lothian

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

MODULE 7: COMMON CONDITIONS AND SOME OF THE DRUGS USED TO TREAT THEM

Chapter 2 ~ Cardiovascular system

DT Description Price Category Price change

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM. 1 April 13

Medicines to treat pain in adults. Information for patients and carers

POLYPHARMACY. A practical approach to deprescribing in care homes. Care Home Pharmacy Team. Herts Valleys Clinical Commissioning Group

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

STOPP and START criteria October 2011

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Ketorolac injection. Supportive care

How to prescribe The elderly. Andi Shirtcliffe Pharmacist

Polypharmacy and Elders. Leslie Baker, Pharm. D., RPh, CGP Sanford Center for Aging

Chapter 2 - Cardiovascular System. Primary Care Prescribing Formulary - Preferred Drug Choices

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

Type 2 Diabetes. Stopping Smoking. Consider referral to smoking cessation. Consider referring for weight management advice.

Meds and Falls: Keep in Step with your Meds

Drug Name: Lithium Clinical Indications: Treatment and prophylaxis of mania; bipolar disorder; augmentation therapy in treatment resistant depression

CHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS

Cardiology. Self Learning Package. Module 5: Pharmacology: Treatment of Acute Coronary. Prevention

Cover images courtesy of jk1991 at FreeDigitalPhotos.net Infographics courtesy of SIMPATHY consortium

Drug Therapy Following Bariatric Surgery

Gateshead Pain Guidelines for Chronic Conditions

Anginal pain is a result of an imbalance between myocardial oxygen supply and demand. Pharmacological management is aimed at prevention of myocardial

Carrying out a structured medication review

Essential Shared Care Agreement: Lithium

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Presented by: Ontario s Geriatric Steering Committee

Appropriate prescribing and deprescribing for older people getting it right. Alan Davis Northland District Health Board

Chapter 4 ~ Central nervous system

BACKGROUND Measuring renal function :

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE. Cranial Health History Form

Specialist palliative care for patients with heart failure. Dr Katie Taylor Consultant in Palliative Medicine

National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL or FAX

Polypharmacy and the Older Adult. Leslie Baker, PharmD, BCGP Umanga Sharma, MD

Chitra Fernando, MD March 18, 2008

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Dose. Route. Units. Given. Special situations. Dose. Route. Units. Given. Special situations

NHS Dumfries & Galloway Aspirin Discontinuation Audit May 2011 (updated August 2015)

Medicines optimisation for older people with disabilities

Polypharmacy and Deprescribing for Older People

Palliative Prescribing - Pain

Repeat Dispensing Handbook

Western University of Health Sciences, College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of

PHARMACOLOGICAL PROBLEMS

Chapter / Section / Drug

Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M %

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.

Transitions of Care & Medication Reconciliation Ashley King, PharmD, BCGP Clinical Pharmacist LECOM Health March 2018

Medicines in Older People- Some of the Key Issues

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

Medications and your Heart. RBCH Foundation Trust

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE

Andrew Dickman Consultant Pharmacist Palliative Care

Medications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.

Patient Group Direction for the supply and/or administration of Ibuprofen 400mg tablets to patients attending NHS Borders services

Berkshire West Area Prescribing Committee Guidance

21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM

Appropriateness of prescribing in older patients

patient group direction

MEDICATION APPROPRIATENESS FOR THE AGING POPULATION. Building Partnerships for Successful Aging

CHARM ASTHMA TREATMENT GUIDELINE

Medicines Formulary BNF Section 4 Central Nervous System

Intervention Study 2016 Trust-wide. Gillian Ritchie Clinical Pharmacist

Platelet aggregation inhibitor. Cardiac chest pain or suspected Myocardial Infarction.

RISK MANAGEMENT PLAN (RMP) PUBLIC SUMMARY ETORICOXIB ORION (ETORICOXIB) 30 MG, 60 MG, 90 MG & 120 MG FILM-COATED TABLET DATE: , VERSION 1.

CLINICAL THERAPEUTICS 2: CARDIOVASCULAR AND RENAL DISEASE (PHAB3FLY)

Transcription:

Prescribing in the Elderly Dr Alison Macrae and Dr Debbie Vest GPST2 Drs in Psychiatry 24 th September 2014

Objectives Understand the significance of polypharmacy in the elderly Become familiar with the STOPP START toolkit Learn how to carry out a medication review Put skills into practice using case studies

Medication review: What do you already know? In pairs, discuss how you would go about the process of reviewing a patient s medication.

Prescribing in the elderly 45% prescriptions are dispensed to over 65 age group Higher prevalence of chronic health conditions & multiple health conditions Physiological changes that occur in the elderly can be interpreted as Physical illness Pharmacokinetics and Pharmacodynamics altered by the ageing process

Pharmacokinetics Reduction renal clearance Accumulation of the drug Caution when prescribing nephrotoxic agents Renally excreted drugs with narrow therapeutic index (e.g. Digoxin) Loss of 1 st pass metabolism Generally leaner body mass;

Hypnotics Diuretics NSAIDs Other drugs; Pharmacodynamics Antiparkinsonian drugs, Antihypertensives, Psychotropics, Digoxin.

Prescribing in the elderly The overall result is the elderly are more at risk of Adverse drug reactions (ADRs) Adverse drug events Drug-drug interactions

Frailty Syndromes (bgs.org.uk)

PRESCRIBING CASCADE

MEDICATION REVIEW N O T E A R S Need and Indication Open Questions Tests and Monitoring Evidence and Guidelines Adverse Events Risk reduction or prevention Simplification and switches

BNF Prescribing in the Elderly Guidelines Limit range Reduce dose Review regularly Simplify regimens Explain clearly Repeats and disposal

STOPP/START Toolkit Screening Tool of Older Person's Prescriptions (STOPP) Screening Tool to Alert doctors to Right Treatment (START)

STOPP/START Toolkit STOPP = 65 clinically significant criteria for potentially inappropriate prescribing in older people. Each criterion is accompanied by a concise explanation as to why the prescribing practice is potentially inappropriate. START = 22 evidence-based prescribing indicators for commonly encountered diseases in older people.

STOPP/START Toolkit

Case Studies - 1 The following table show the medication prescribed for a 75 year old woman with multiple co-morbidities. Four specialists were involved in the care of the lady. She had IHD, paroxysmal AF, and a number of her cardiac medications were initiated following acute hospital admissions. She also had frequent infective exacerbations of COPD and suffered from various GI problems, Parkinson s Disease and Anxiety

Case Studies - 1 INDICATION MEDICATION FORMULATION, DOSE, FREQUENCY Coronary heart disease with paroxysmal atrial fibrillation and MI Aspirin Simvastatin Verapamil hydrochloride Digoxin GTN Furosemide 75mg dispersible once daily 40mg one at night 240mg MR one in the morning 125mcg tablets one at night Sublingual spray 1-2 PRN 40mg one in the morning COPD with bronchiectasis Seretide Ventolin 250/actuation 2 puffs twice daily 100/actuation 2 puffs four times a day Dyspepsia, previous history of peptic ulcer, biliary reflux, previous history of portal vein thrombosis and portal hypertension with oesophageal varices and irritable bowel syndrome, constipation Peptac Omeprazole Domperidone Mebeverine hydrochloride Docusate sodium Senna Glycerol Liquid 5-10ml PRN 20mg enteric coated twice daily 20mg tablets three times a day 265mg three times a day 200mg twice a day 7.5mg PRN for constipation 700mg suppositories PRN Parkinson s disease Ropinirole hydrochloride Amatadine hydrochloride Co-careldopa Co-careldopa Co-benyldopa 8mg M/R tablets three in morning 100mg once a day morning 25/100 1.4 breakfast/lunch/supper 50/200 MR at night 125/50 dispersible in the morning Anxiety Amitriptyline hydrochloride 25mg one in the morning and two at night

Case Studies - 1 Perform a medication review Discuss how you could approach rationalising medication Are there any medications you would stop or start? Who else would you need to involve in this process?

Case Studies - 2 This case is of a 60 year old woman, managed by her GP who had breast cancer diagnosed 5 years ago which was initially treated with Herceptin. She developed metastatic disease, with pain in the thoracic spine and right hypochondrium, and experienced a fit probably due to brain metastases. She had been taking tramadol for a few weeks for pain and was started on a fentanyl transdermal patch a few days ago. She had become increasingly tired and nauseated and was unable to attend the GP surgery requiring home visits. She had been on a long-term statin for hypercholesterolaemia, took an SSRI antidepressant and complained of dyspepsia. She also had heart failure attributed to previous herceptin therapy and remained short of breath.

Case Studies - 2 INDICATION MEDICATION FORMULATION, DOSE, FREQUENCY Pain Paracetamol Naproxen Ibuprofen Tramadol 500mg two, four times a day 250mg three times a day 500mg three times a day 50mg 1-2 PRN up to four times a day Depression Fluoxetine St John s Wort 20mg capsules one in the morning One daily (over the counter) Heart failure Primary cardiovascular risk prophylaxis Dyspepsia Furosemide Ramipril Simvastain Aspirin Gaviscon advance Co-magaldrox 40mg tablet one in the morning 5mg tablets twice a day 40mg one at night 75mg once a day 5-10ml PRN for indigestion 195/220 suspension 10-20mls after meals Breast cancer Tamoxifen 20mg tablets once a day

Case Studies - 2 Perform a medication review Discuss how you could approach rationalising medication Are there any medications you would stop or start? Who else would you need to involve in this process?

Case Studies - 3 This concerns a 90 year old woman who had a previous history of myocardial infarction, severe aortic stenosis and heart failure. She also suffered from asthma, osteoporosis and hypothyroidism. She underwent aortic valve replacement and was discharged to a care home on the following medicines, where her care was primarily managed by her GP.

Case Studies - 3 INDICATIONS MEDICATION FORMULATION, DOSE AND FREQUENCY Coronary heart disease, heart failure Isosorbide mononitrate Digoxin Bumetanide Simvastatin Clopidogrel Captopril Bendroflumethiazide Amiodarone GTN 60mg MR once a day 62.5mcg once a day 1mg four in the morning 40mg one at night 75mg once a day 25mg twice daily 2.5mg once in the morning 200mg once daily S/L 1-2 puffs for angina Asthma Salbutamol 100micrograms/puff Osteoperosis Calcichew D3 forte 1.25g tablets twice daily Prophylaxis against GI bleed Lansoprazole 30mg once daily Hypothyroidism Levothryoxine 50microgram tablets once a day

Case Studies - 3 Perform a medication review Discuss how you could approach rationalising medication Are there any medications you would stop or start? Who else would you need to involve in this process?

AKT QUESTION You see an 80 year old patient who is rarely at the practice but used to see a now retired partner. She is usually well but has been falling more recently. She is worried about breaking a hip. Her medications include amtitryptyline, diazepam, temazepam, bendroflumethiazide, atenolol, aspirin and simvastatin.

ANSWERS A B C D E Stop aspirin Stop simvastatin Reduce to four or fewer medications Stop amytriptyline Stop bendroflumethiazide

Objectives Understand the significance of polypharmacy in the elderly Become familiar with the STOPP START toolkit Learn how to carry out a medication review Put skills into practice using case studies

References & Suggested Further Reading Optimising drug treatment for elderly people: the prescribing cascade. Rochon P A, and Gurwitz J H BMJ 1997;315:1096-1099 Tessa Lewis. Using the NO TEARS tool for medication review. BMJ 2004 Vol 329, 433-434

References & Suggested Further Reading The Silver Book - www.bgs.org.uk STOPP START (NHS Cumbria); http://www.cumbria.nhs.uk/professionalzone/medicin esmanagement/guidelines/stopstarttoolkit2011.pdf Amercian Geriatric Society updated Beers Criteria; http://www.americangeriatrics.org/files/documents/b eers/2012beerscriteria_jags.pdf BNF (via GMC) Prescribing in the elderly; https://www.medicinescomplete.com/mc/bnf/current/ PHP139-prescribing-for-the-elderly.htm